Anti-Mouse MHC Class I (H-2Kd) [Clone SF1.1.10] — Purified in vivo GOLD™ Functional Grade
Anti-Mouse MHC Class I (H-2Kd) [Clone SF1.1.10] — Purified in vivo GOLD™ Functional Grade
Product No.: H702
| Clone SF1.1.10 Formats AvailableView All Product Type Hybridoma Monoclonal Antibody Isotype Mouse IgG2a k |
| Select Product Size | Qty Max: Min: 1 Step: 1 Select A Size |
Antibody DetailsProduct DetailsRecommended Dilution Buffer Product Concentration ≥ 5.0 mg/ml Endotoxin Level < 1.0 EU/mg as determined by the LAL method Purity ≥95% monomer by analytical SEC ⋅ >95% by SDS Page Formulation This monoclonal antibody is aseptically packaged (0.2um filtered) and formulated in 0.01 M PBS (phosphate buffered saline) (150 mM NaCl) pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. State of Matter Liquid Product Preparation Functional grade preclinical antibodies are manufactured in an animal free facility using only in vitro protein free cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. Storage and Handling Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at ≤ -70°C. Avoid Repeated Freeze Thaw Cycles. Regulatory Status Research Use Only Country of Origin USA Shipping 2 – 8° C Additional Applications Reported In Literature ? Purification of MHC peptide complexes, in vivo, FC Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionBackground MHC class I molecules are cell-surface glycoproteins expressed on nearly all nucleated cells. Each molecule is made of a polymorphic heavy chain paired with B2-microglobulin, and the a1 and a2 domains of the heavy chain form a groove that holds a short peptide (1, 2). These peptide–MHC complexes display intracellular proteins to CD8⁺ cytotoxic T cells, which allows the immune system to detect and eliminate virus-infected or transformed cells (2, 3). MHC class I also engages inhibitory receptors on NK cells, so cells that lose class I expression become targets for NK-mediated killing (4). H-2Kd is the K-locus class I allele of the H-2d haplotype and is expressed by mouse strains such as BALB/c and DBA/2. Clone SF1.1.10 (ATCC HB-159) is a mouse IgG2a monoclonal antibody that recognizes H-2Kd, so it can distinguish H-2d cells from cells of mismatched haplotypes, such as H-2b C57BL/6 cells. Researchers use it for MHC haplotype typing, for tracking donor versus host cells in bone marrow chimeras and transplantation models, and for studies of alloreactivity and graft-versus-host disease (5). Leinco Antibody AdvisorPowered by AI: AI is experimental and still learning how to provide the best assistance. It may occasionally generate incorrect or incomplete responses. Please do not rely solely on its recommendations when making purchasing decisions or designing experiments. Clone 34-1-2S is most commonly applied in vivo in mice for the functional blockade and depletion of MHC class I molecules (H-2Kd, H-2Dd), manipulation of antigen presentation to CD8+ T cells, and experimental studies of immune responses involving cytotoxic T lymphocytes. Key in vivo applications include:
These applications exploit the specificity of 34-1-2S for a common epitope in the α3 domain of H-2Kd and H-2Dd, enabling the selective targeting of these mouse MHC class I haplotypes in vivo. Dosage and administration routes are determined empirically for specific experimental goals and require careful titration to avoid off-target effects. The most commonly used antibodies or proteins in combination with 34-1-2S (which targets mouse MHC Class I, specifically H-2Kd and H-2Dd) in the literature are those involved in immune cell characterization and antigen presentation studies. While specific pairings vary by experiment, several commonly co-used antibodies and proteins include:
These antibodies and proteins are typically used in applications such as:
In summary, the most commonly paired antibodies/proteins with 34-1-2S are those targeting CD8, CD3/TCR, other MHC Class I molecules (like H-2Kb), lineage markers (CD45, CD4, CD19), β2 microglobulin, and isotype controls, depending on the experimental context. Clone 34-1-2S is a widely cited monoclonal antibody used for identifying and studying mouse MHC class I antigens, specifically H-2K(^d) and H-2D(^d), with notable applications and biological findings in immunology and transplantation research. Key findings from its scientific literature citations include:
Summary Table: Key Attributes of 34-1-2S in Literature
These findings highlight 34-1-2S as a foundational tool for mouse MHC class I research, with ongoing impact demonstrated in both basic and translational immunology. The dosing regimens for the 34-1-2S monoclonal antibody, which targets MHC Class I H-2Kd and H-2Dd in mice, primarily depend on the application rather than the mouse model itself. This antibody is commonly used in flow cytometric analysis to study the expression of MHC class I antigens on nucleated cells from mice of the H-2Kd/H-2Dd haplotype. General Guidelines for Use:
Variation Considerations:While there is no detailed information on varying dosing regimens across different mouse models for clone 34-1-2S specifically, dosing strategies in immunological research often depend on the experimental goals (e.g., depletion of specific cell subsets, modulation of immune responses). However, for most applications involving this antibody, the dosage is standardized for flow cytometry rather than being tailored to specific mouse models. References & Citations1. Bjorkman P.J. et al. (1987) Nature 329:506–512. 2. Neefjes J. et al. (2011) Nat. Rev. Immunol. 11:823–836. 3. Zinkernagel R.M. and Doherty P.C. (1974) Nature 248:701–702. 4. Kärre K. et al. (1986) Nature 319:675–678. |
Formats Available
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
